The USA, UK and Europe have recently approved the JAK inhibitor baricitinib/Olumiant® to treat severe cases of adult alopecia areata (AA). However, despite these good news, JAK inhibitors are still in an early stage of clinical investigation and until now …
Press Release – New Publication: An advocacy to use humanized mouse models for psoriasis research and pre-clinical drug development
Psoriasis is a chronic inflammatory skin disease characterized by dry, itchy and scaly patches. Patients suffer greatly from both, the negative features of the symptoms as well as psychologically from i.e. poor self-esteem or social isolation. For the development of …